Related Experiment Video
Updated: Feb 26, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
KCNA2 variants cause dilated cardiomyopathy, obesity and sleep apnea through RAC-ERK pathway
Prasanth Chimata1,2, Sahil Lall3, Tarmo Annilo4
1Cardiovascular Development and Disease Mechanisms, Institute for Stem Cell Science and Regenerative Medicine (BRIC-inStem), Bengaluru, Karnataka, 560065, India.
Insights
Genetic KCNA2 variants are linked to a heart condition (DCM), obesity, and sleep apnea (DOSA). These variants cause ion channel dysfunction, impacting heart function and leading to DOSA phenotypes.
Area of Science:
- Cardiovascular Genetics
- Channelopathies
- Systems Biology
Background:
- Dilated cardiomyopathy (DCM) involves heart dysfunction, often co-occurring with obesity and sleep apnea.
- The genetic basis for these combined phenotypes (DCM, obesity, sleep apnea - DOSA) remains largely unknown.
Purpose of the Study:
- To investigate the genetic underpinnings of patients presenting with DCM, obesity, and sleep apnea (DOSA).
- To elucidate the functional consequences of identified genetic variants in disease pathogenesis.
Main Methods:
- Next-generation sequencing to identify genetic variants in DOSA patients.
- Electrophysiological and biochemical assays using biosensors to assess variant function.
- Patient-derived iPSC cardiomyocytes and organoid models for cellular studies.
- Drosophila melanogaster model to validate in vivo phenotypes and therapeutic targets.
Main Results:
- Pathogenic KCNA2 variants were identified in diverse ancestry DOSA patients.
- KCNA2 variants led to loss of membrane current due to cellular trafficking defects.
- Hyperactivation of the RAC1-ERK1/2 pathway was observed in cellular models.
- A Drosophila model exhibited DOSA-like phenotypes, reversible with RAC1 inhibitors.
Conclusions:
- This study provides the first evidence linking KCNA2 variants to the combined phenotypes of DCM, obesity, and sleep apnea (DOSA).
- KCNA2 variants disrupt potassium channel function, contributing to DOSA pathogenesis via RAC1-ERK1/2 pathway dysregulation.
- These findings expand the known roles of potassium channels in complex human diseases.
Abstract:
Dilated cardiomyopathy (DCM) is a heart condition characterized by systolic and diastolic dysfunction. In many instances, patients with DCM coexist with obesity and sleep apnea. It is unclear whether genetic variants contribute to the combined phenotypes of DCM, obesity, and sleep apnea. Here, using next-generation sequencing, we identified pathogenic KCNA2 variants in patients of diverse ancestry with DCM, Obesity, and Sleep Apnea (termed DOSA). Electrophysiological and biochemical assays using biosensors revealed loss of membrane current due to trafficking defects in cells expressing KCNA2 variants. Furthermore, cellular models including patient-specific iPSC cardiomyocytes and organoid models displayed RAC1-ERK1/2 hyperactivation in disease pathogenesis. A Drosophila model expressing KCNA2 variant showed DOSA-like phenotypes which was rescued using RAC1 inhibitors. Our results provide the first evidence that KCNA2 variants can lead to DOSA phenotypes, further expanding the genetic regulatory roles of potassium channels in human diseases.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
MAPK Signaling Cascades
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Sleep Apnea
The condition is more prevalent among...
cAMP-dependent Protein Kinase Pathways
Cardiomyopathy IV: Restrictive Cardiomyopathy